Assessing benefit in trials: Are we making progress in assessing progression in cancer clinical trials?

Author： Dancey Janet E.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|11|1728-1730

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.11, 2015-06, pp. : 1728-1730

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Applying Proteomics in Clinical Trials: Assessing the Potential and Practical Limitations in Ovarian Cancer

By Tchabo Nana E.   Liel Meghan S.   Kohn Elise C.  

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 141-148

Adis International

Access to resources Recommend Favorite

Assessing Outcome in Head Injury Trials

By  

Current Pharmaceutical Design, Vol. 7, Iss. 15, 2001-10 ,pp. : 1537-1552

Bentham Science Publishers

Access to resources Recommend Favorite

Research Outcomes and Recommendations for the Assessment of Progression in Cancer Clinical Trials

By Bushnell Will   Stone Andrew  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 949-950

Taylor & Francis Ltd

Access to resources Recommend Favorite

Adaptive Clinical Trials: Progress and Challenges

By Coffey Christopher S.  

Drugs in R&D, Vol. 9, Iss. 4, 2008-01 ,pp. : 229-242

Adis International

Access to resources Recommend Favorite

Clinical trials report on ongoing trials in lung cancer

By Giaccone G.   van Meerbeck J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1939-1950

Informa Healthcare

Access to resources Recommend Favorite